A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children

NCT00319670 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Constipation

Interventions

DRUG: MiraLax

Sponsor

Braintree Laboratories